AAAAAA
Results:
1-17
|
Results: 17
Authors:
ESTROV Z
TALPAZ M
KU S
HARRIS D
VAN Q
BERAN M
HIRSCHGINSBERG C
HUH Y
YEE G
KURZROCK R
Citation: Z. Estrov et al., Z-138 - A NEW MATURE B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE FROM A PATIENT WITH TRANSFORMED CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia research, 22(4), 1998, pp. 341-353
Authors:
HIRSCHGINSBERG C
Citation: C. Hirschginsberg, DETECTION OF MINIMAL RESIDUAL DISEASE - RELEVANCE FOR DIAGNOSIS AND TREATMENT OF HUMAN MALIGNANCIES, Annual review of medicine, 49, 1998, pp. 111-122
Authors:
ALBITAR M
WU WIC
FELTZ E
JIN GH
HIRSCHGINSBERG C
KANTARJIAN H
BERAN M
Citation: M. Albitar et al., SIMPLIFIED REVERSE DOT-BLOT ANALYSES FOR DETECTING RAS ONCOGENE MUTATIONS, Molecular diagnosis, 2(3), 1997, pp. 169-176
Authors:
WEINKAUFF R
STAROSTIK P
HAYES K
HUH YO
HIRSCHGINSBERG C
BUESORAMOS C
ANDREEFF M
KEATING M
KANTARJIAN H
FREIREICH E
ESTEY E
ALBITAR M
Citation: R. Weinkauff et al., USE OF PERIPHERAL-BLOOD BLASTS VERSUS BONE-MARROW BLASTS FOR DIAGNOSIS OF ACUTE-LEUKEMIA, Blood, 90(10), 1997, pp. 3746-3746
Authors:
ESTROV Z
TALPAZ M
ZIPF TF
KANTARJIAN HM
KU S
OUSPENSKAIA MV
HIRSCHGINSBERG C
HUH Y
YEE G
KURZROCK R
Citation: Z. Estrov et al., ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PHILADELPHIA (PH(1))-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA - STUDIES ON 2 NEWLYESTABLISHED PH(1)-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES (Z-119 AND Z-181), Journal of cellular physiology, 166(3), 1996, pp. 618-630
Authors:
VERSCHRAEGEN CF
KANTARJIAN HM
HIRSCHGINSBERG C
LEE MS
OBRIEN S
RIOS MB
STASS SA
KEATING M
TALPAZ M
Citation: Cf. Verschraegen et al., THE BREAKPOINT CLUSTER REGION SITE IN PATIENTS WITH PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA - CLINICAL, LABORATORY, AND PROGNOSTIC CORRELATIONS, Cancer, 76(6), 1995, pp. 992-997
Authors:
GIRALT S
HESTER J
HUH Y
HIRSCHGINSBERG C
RONDON G
SEONG D
LEE M
GAJEWSKI J
VANBESIEN K
KHOURI I
MEHRA R
PRZEPIORKA D
KORBLING M
TALPAZ M
KANTARJIAN H
FISCHER H
DEISSEROTH A
CHAMPLIN R
Citation: S. Giralt et al., CD8-DEPLETED DONOR LYMPHOCYTE INFUSION AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(11), 1995, pp. 4337-4343
Authors:
FERRAJOLI A
TALPAZ M
ORDONEZ NG
STANLEY ER
HIRSCHGINSBERG C
ZIPF TF
WETZLER M
KURZROCK R
ESTROV Z
Citation: A. Ferrajoli et al., INTERLEUKIN-4 ALTERS HUMAN BONE-MARROW STROMA AND MODULATES ITS INTERACTION WITH HEMATOPOIETIC PROGENITORS, Stem cells, 12(6), 1994, pp. 638-649
Authors:
FERRAJOLI A
TALPAZ M
ZIPF TF
HIRSCHGINSBERG C
ESTEY E
WOLPE SD
ESTROV Z
Citation: A. Ferrajoli et al., INHIBITION OF ACUTE MYELOGENOUS LEUKEMIA PROGENITOR PROLIFERATION BY MACROPHAGE INFLAMMATORY PROTEIN 1-ALPHA, Leukemia, 8(5), 1994, pp. 798-805
Authors:
PRETI A
KANTARJIAN HM
ESTEY E
HUH Y
KEATING M
PIERCE S
HIRSCHGINSBERG C
YEE G
STASS SA
Citation: A. Preti et al., CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA AND MYELOPEROXIDASE-POSITIVE BLASTS BY ELECTRON-MICROSCOPY, Hematologic pathology, 8(4), 1994, pp. 155-167
Authors:
PRETI A
KANTARJIAN HM
ESTEY E
HUH Y
KEATING M
PIERCE S
HIRSCHGINSBERG C
YEE G
STASS SA
Citation: A. Preti et al., CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA AND MYELOPEROXIDASE-POSITIVE BLASTS BY ELECTRON-MICROSCOPY, Hematologic pathology, 8(4), 1994, pp. 155-167
Authors:
GIRALT S
HESTER J
HUH Y
HIRSCHGINSBERG C
RONDON G
GUO J
LEE M
GAJEWSKI J
TALPAZ M
KANTARJIAN H
FISCHER H
DEISSEROTH A
CHAMPLIN R
Citation: S. Giralt et al., CD8-MARROW TRANSPLANTATION (BMT) - GRAFT VS LEUKEMIA WITHOUT GRAFT-VS-HOST DISEASE (GVHD)( DEPLETED DONOR LYMPHOCYTE INFUSION AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER ALLOGENEIC BONE), Blood, 84(10), 1994, pp. 10000538-10000538
Authors:
ROBERTSON LE
PUGH W
OBRIEN S
KANTARJIAN H
HIRSCHGINSBERG C
CORK A
MCLAUGHLIN P
CABANILLAS F
KEATING MJ
Citation: Le. Robertson et al., RICHTERS-SYNDROME - A REPORT ON 39 PATIENTS, Journal of clinical oncology, 11(10), 1993, pp. 1985-1989
Authors:
GIRALT S
ESCUDIER S
KANTARJIAN H
DEISSEROTH A
FREIREICH EJ
ANDERSSON BS
OBRIEN S
ANDREEFF M
FISHER H
CORK A
HIRSCHGINSBERG C
TRUJILLO J
STASS S
CHAMPLIN RE
Citation: S. Giralt et al., PRELIMINARY-RESULTS OF TREATMENT WITH FILGRASTIM FOR RELAPSE OF LEUKEMIA AND MYELODYSPLASIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, The New England journal of medicine, 329(11), 1993, pp. 757-761
Authors:
VERSCHRAEGEN C
KANTARJIAN H
HIRSCHGINSBERG C
LEE M
CORK A
OBRIEN S
STASS S
RIOS M
TALPAZ M
Citation: C. Verschraegen et al., CORRELATION BETWEEN DENSITOMETRY QUANTITATION OF THE BREAKPOINT CLUSTER REGION REARRANGEMENT (BCR-CHROMOSOME-POSITIVE (PH+) CHRONIC MYELOGENOUS LEUKEMIA (CML)() AND STANDARD CYTOGENETIC (CG) ANALYSIS IN PATIENTS WITH PHILADELPHIA), Blood, 82(10), 1993, pp. 10000042-10000042
Authors:
PRETI A
OBRIEN S
ROBERTSON L
BERAN M
HUH Y
KOLLER C
HIRSCHGINSBERG C
ANDREEFF M
STASS S
KANTARJIAN H
Citation: A. Preti et al., CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) AND MYELOPEROXIDASE POSITIVE BLASTS BY ELECTRON-MICROSCOPY (EM-MPO-POSITIVE), Blood, 82(10), 1993, pp. 10000057-10000057
Authors:
VERSCHRAEGEN C
KANTARJIAN H
HIRSCHGINSBERG C
LEE M
CORK A
OBRIEN S
RIOS M
STASS S
TALPAZ M
Citation: C. Verschraegen et al., PROGNOSTIC RELEVANCE OF 3' VERSUS 5' BREAKPOINTS (BP) WITHIN THE BREAKPOINT CLUSTER REGION OF CHROMOSOME-22 IN PHILADELPHIA-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (PH+CML), Blood, 82(10), 1993, pp. 10000331-10000331
Risultati:
1-17
|